Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
KOMBIGLYZE™ XR (Saxagliptin and Metformin HCl Extended-Release) tablets approved in the U.S. for the treatment of Type 2 diabetes mellitus in adults — the first and only once-a-day metformin extended-release (XR) plus DPP-4 inhibitor combination tablet.
FDA Rejects Another New Diabetes Drug – Linjeta, a new rapid acting insulin. FDA issued a Complete Response Letter, requesting additional information. Linjeta (formally VIAject) is a more rapid-acting form of injectable human insulin for meal-time use by patients with Type 1 or Type 2 diabetes.